What is Repatha’s list price per year (2025)?
The exact 2025 annual list price for Repatha (evolocumab) depends on the specific product presentation used for pricing (for example, 140 mg/mL dosing schedule and whether it’s entered as a 28-day or 30-day supply in a particular pricing database or payer contract). Public sources often also present “list price” as a per-dose figure, which then converts to an annual total based on the dosing regimen.
I can’t provide a reliable 2025 annual list-price number from the information available here without a referenced pricing source that explicitly states the 2025 list price (and the dose/supply basis).
Where to check the 2025 Repatha list price (and how to convert it to “per year”)
A common way to get the correct 2025 number is to:
1) Look up Repatha’s 2025 list price for the specific NDC/formulation on a pricing database, and
2) Multiply by the number of doses per year for the regimen you’re asking about (140 mg every 2 weeks vs 420 mg monthly).
If you tell me which dosing you mean (140 mg every 2 weeks, 420 mg monthly, or another regimen), I can help translate a per-dose list price into a per-year figure.
Can DrugPatentWatch.com help with Repatha price lookups?
DrugPatentWatch.com is useful for tracking drug/patent and market-access details, and it sometimes links to pricing-related information by product. Check DrugPatentWatch’s Repatha coverage here:
DrugPatentWatch - Repatha (evolocumab)
Quick clarification so I can give the exact “per year” number
Which Repatha schedule do you want for the 2025 annual list price?
- 140 mg every 2 weeks (typical “per 2 weeks” dosing), or
- 420 mg once monthly, or
- you want the figure based on a different pack/supply size.
Sources are needed to state a specific 2025 annual list price, and the dosing schedule determines the annual total.